ARK Investment Management UROGEN PHARMA LTD COM ownership

UROGEN PHARMA LTD COM's ticker is URGN and the CUSIP is M96088105. A total of 5 filers reported holding UROGEN PHARMA LTD COM in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

ARK Investment Management ownership history of UROGEN PHARMA LTD COM
ValueSharesWeighting
Q2 2022$1,607
-44.7%
302,124
-9.4%
0.01%
-16.7%
Q1 2022$2,905
+63.8%
333,472
+78.8%
0.01%
+140.0%
Q4 2021$1,774
-56.8%
186,493
-23.6%
0.01%
-50.0%
Q3 2021$4,107
-15.0%
244,165
-22.8%
0.01%
+11.1%
Q2 2021$4,829
-15.1%
316,248
+8.4%
0.01%
-18.2%
Q1 2021$5,686
+327.8%
291,870
+295.7%
0.01%
+175.0%
Q4 2020$1,329
+101.4%
73,769
+115.6%
0.00%0.0%
Q3 2020$660
-46.5%
34,212
-27.5%
0.00%
-69.2%
Q2 2020$1,233
+311.0%
47,208
+180.6%
0.01%
+85.7%
Q1 2020$300
-43.9%
16,821
+5.0%
0.01%
-46.2%
Q4 2019$535
+57.8%
16,025
+12.6%
0.01%
+85.7%
Q3 2019$339
-30.2%
14,235
+5.2%
0.01%
-41.7%
Q2 2019$486
+45.9%
13,529
+50.2%
0.01%
+20.0%
Q1 2019$333
-31.5%
9,007
-20.3%
0.01%
-50.0%
Q4 2018$486
-8.6%
11,298
+0.4%
0.02%
+25.0%
Q3 2018$532
+13.2%
11,258
+19.3%
0.02%
-5.9%
Q2 2018$470
-30.0%
9,438
-30.1%
0.02%
-48.5%
Q1 2018$671
+94.5%
13,502
+45.4%
0.03%
+22.2%
Q4 2017$3459,2840.03%